David Bin‐Chia Wu

1.4k total citations · 1 hit paper
35 papers, 959 citations indexed

About

David Bin‐Chia Wu is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Economics and Econometrics. According to data from OpenAlex, David Bin‐Chia Wu has authored 35 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Economics and Econometrics. Recurrent topics in David Bin‐Chia Wu's work include Respiratory viral infections research (7 papers), Influenza Virus Research Studies (6 papers) and Pneumonia and Respiratory Infections (5 papers). David Bin‐Chia Wu is often cited by papers focused on Respiratory viral infections research (7 papers), Influenza Virus Research Studies (6 papers) and Pneumonia and Respiratory Infections (5 papers). David Bin‐Chia Wu collaborates with scholars based in Malaysia, United States and Thailand. David Bin‐Chia Wu's co-authors include Nathorn Chaiyakunapruk, Huey Yi Chong, Surachai Kotirum, Siew Li Teoh, Chiun‐Fang Chiou, Tahir Mehmood Khan, Anton V. Dolzhenko, Philippe Beutels, Richard Chambers and Ajaree Rayanakorn and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

David Bin‐Chia Wu

34 papers receiving 938 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global economic burden of schizophrenia: a systematic review

2016 460 citations Nathorn Chaiyakunapruk, Huey Yi Chong et al. profile →

Peers

Countries citing papers authored by David Bin‐Chia Wu

Since Specialization

Citations

This map shows the geographic impact of David Bin‐Chia Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bin‐Chia Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bin‐Chia Wu more than expected).

Fields of papers citing papers by David Bin‐Chia Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Bin‐Chia Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bin‐Chia Wu. The network helps show where David Bin‐Chia Wu may publish in the future.

Co-authorship network of co-authors of David Bin‐Chia Wu

This figure shows the co-authorship network connecting the top 25 collaborators of David Bin‐Chia Wu. A scholar is included among the top collaborators of David Bin‐Chia Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Bin‐Chia Wu. David Bin‐Chia Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-World Epidemiology, Clinical and Economic Burden of Chronic Hepatitis B in Japan: A Retrospective Study Using JMDC Claims Database 2023 ·Infectious Diseases and Therapy ·Takeji Umemura, (unknown), (unknown), Yasushi Takahashi, (unknown), (unknown), Angelina Villası́s-Keever, Martina Furegato, (unknown), (unknown), (unknown), David Bin‐Chia Wu	11
2	Validating the Prognostic Utility of the ABCD-GENE Score in Asian Patients with Acute Coronary Syndrome Patients on Clopidogrel 2023 ·European Cardiology Review ·(unknown), David Bin‐Chia Wu, (unknown), (unknown), (unknown), Doreen Su‐Yin Tan	1
3	The Evaluation of home medication review for patients with type 2 diabetes mellitus by community pharmacists: a randomised controlled trial 2021 ·Pharmacy Practice ·(unknown), Chin Fen Neoh, David Bin‐Chia Wu, (unknown), (unknown), (unknown), Mahmathi Karuppannan	13
4	Cost-Effectiveness of Adjuvant Trastuzumab Therapy for Early Breast Cancer in Asia: A Systematic Review 2019 ·Value in Health Regional Issues ·(unknown), Yet Hoi Hong, David Bin‐Chia Wu, (unknown), Chin Fen Neoh	7
5	A comparison of 6 osteoporosis risk assessment tools among postmenopausal women in Kuala Lumpur, Malaysia 2019 ·SHILAP Revista de lepidopterología ·(unknown), Pauline Siew Mei Lai, David Bin‐Chia Wu, Brian Bell, (unknown), (unknown), (unknown), Giuseppe Guglielmi, Claire Anderson	14
6	Cost-effectiveness analysis of bilateral cochlear implants for children with severe-to-profound sensorineural hearing loss in both ears in Singapore 2019 ·PLoS ONE ·(unknown), (unknown), David Bin‐Chia Wu, (unknown), Kwong Ng	16
7	Economic Evaluation of Combination Therapy Versus Monotherapy for Treatment of Benign Prostatic Hyperplasia in Hong Kong 2018 ·Frontiers in Pharmacology ·David Bin‐Chia Wu, (unknown), Chi‐Fai Ng, Shaun Wen Huey Lee, Nathorn Chaiyakunapruk, (unknown), (unknown)	2
8	Cost-utility analysis of antiviral use under pandemic influenza using a novel approach – linking pharmacology, epidemiology and heath economics 2018 ·Epidemiology and Infection ·David Bin‐Chia Wu, Nathorn Chaiyakunapruk, Chayanin Pratoomsoot, (unknown), Huey Yi Chong, Richard E. Nelson, Patrick F. Smith, Carl M. J. Kirkpatrick, (unknown), Keith Nieforth, (unknown), Stephen Toovey, David C. M. Kong, (unknown), Craig R. Rayner	10
9	The Effects of Mindfulness on Older Adults with Mild Cognitive Impairment 2017 ·Journal of Alzheimer s Disease Reports ·(unknown), Jan Coles, Richard Chambers, David Bin‐Chia Wu, Craig Hassed	46
10	Economic Evaluation and Budget Impact Analysis of Vaccination against Haemophilus influenzae Type b Infection in Thailand 2017 ·Frontiers in Public Health ·Surachai Kotirum, Charung Muangchana, (unknown), Piyameth Dilokthornsakul, David Bin‐Chia Wu, Nathorn Chaiyakunapruk	5
11	Knowledge, attitude and awareness among healthcare professionals about influenza vaccination in Peshawar, Pakistan 2016 ·Vaccine ·Tahir Mehmood Khan, Aziz Khan, Iftikhar Ali, David Bin‐Chia Wu	30
12	Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review 2016 ·PharmacoEconomics ·Surasak Saokaew, Ajaree Rayanakorn, David Bin‐Chia Wu, Nathorn Chaiyakunapruk	34
13	Cost-effectiveness analysis of infant universal routine pneumococcal vaccination in Malaysia and Hong Kong 2015 ·Human Vaccines & Immunotherapeutics ·David Bin‐Chia Wu, Craig S. Roberts, Vivian Lee, (unknown), Kah Kee Tan, Vivienne Mak, (unknown)	30
14	Assessing the cost-effectiveness of a Universal Rotavirus Vaccination program for the Philippines using a dynamic transmission model 2015 ·Value in Health ·Hilton Y. Lam, David Bin‐Chia Wu, Adovich S. Rivera, Marissa M. Alejandria, (unknown), (unknown), (unknown), Jacinto Blas Mantaring, (unknown)	2
15	Choosing between 7-, 10- and 13-valent pneumococcal conjugate vaccines in childhood: A review of economic evaluations (2006–2014) 2015 ·Vaccine ·David Bin‐Chia Wu, Nathorn Chaiyakunapruk, (unknown), Philippe Beutels	34
16	The Health and Economic Effects on Public Health Due to Patients’ Default in Tuberculosis Treatment in Malaysia 2013 ·Value in Health ·Weng Hong Fun, David Bin‐Chia Wu, (unknown), (unknown), (unknown), (unknown)	1
17	Estimating the cost-effectiveness of belimumab versus standard care for sle patients in Hong Kong 2013 ·Value in Health ·(unknown), (unknown), David Bin‐Chia Wu, Adrian Goh	2
18	Economic evaluation of ticagrelor in treating patients with acute coronary syndrome in hong kong: A cost-utility analysis 2013 ·Value in Health ·David Bin‐Chia Wu, (unknown), (unknown)	0
19	Cost analysis of risperidone long-acting injection in the treatment of schizophrenia and schizoaffective disorders in Hong Kong: An approach using generalised estimating equations 2013 ·Psychiatry Research ·David Bin‐Chia Wu, Edwin Lee, (unknown), (unknown), Vivian Lee, (unknown), (unknown)	8
20	Cost-Effectiveness Analysis of Pneumococcal Conjugate Vaccine in Taiwan: A Transmission Dynamic Modeling Approach 2012 ·Value in Health ·David Bin‐Chia Wu, Chee‐Jen Chang, (unknown), (unknown), Chia‐Ling Wu, Cathy S.J. Fann	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact